Tag: NCCN Guidelines

ICARE Newsletter Fall 2026

National Comprehensive Cancer Network (NCCN) Guidelines Update: Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric (Version 1.2026)

The panel set a specific minimal set of genes to test for colorectal, endometrial, and gastric cancer: COLORECTAL CANCER GENES(including genes that predispose to polyps) Additional genes that sometimes get included: ATM, BLM, CHEK2, GALNT12, RNF43, and RPS20. ENDOMETRIAL (UTERINE) CANCER GENES GASTRIC CANCER GENES Test selection and decision to retest including additional genes beyond these …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf20262/

ICARE Newsletter Fall 2026

National Comprehensive Cancer Network (NCCN) Guidelines Update: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2027)

GENE TABLES EXPANDED GENETIC TESTING Testing may be appropriate for some individuals with a close family member who meets testing criteria but has not had genetic testing. This helps expand access to testing for families seeking answers (CRIT-2 & 6), while acknowledging that testing the affected family member is most informative (CRIT-2, 4, 6A, 7, …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf20261/

ICARE Social Media Post October 2025

NCCN Navigator

🚀 Introducing the NCCN Guidelines Navigator™ – Version 1.2026! Explore this new interactive, color-coded platform designed to simplify navigation of NCCN’s Genetics/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate cancer guidelines. Whether you’re a clinician, researcher, or advocate, this tool helps you stay informed and make confident decisions in cancer care. Start exploring now by …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post10082025/